Sickle Cell Patients Celebrated in New Brunswick
Five young patients were recognized for their successful recovery following specialized treatment in New Jersey.
Updated on Sept. 30, 2026 in Stroke
Five young patients have been recognized for their successful recovery from sickle cell disease after undergoing bone marrow transplants or gene therapy. The patients and their families gathered in New Brunswick to mark their health milestones.
Why it matters
These advanced medical procedures, performed by RWJBarnabas Health and the Rutgers Cancer Institute, offer a potential cure for those suffering from the chronic symptoms of sickle cell disease. Successful outcomes demonstrate the effectiveness of these treatments in eliminating the need for long-term medication.
Five young patients were recognized at the gathering, including six-year-old Tiara who is now one year post-transplant and free of disease-related medication. This recovery represents a significant milestone in their treatment journeys.
The players
RWJBarnabas Health
This is the largest academic health care system in New Jersey and was a key provider in the patients' treatment.
Rutgers Cancer Institute
This is New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center that collaborated on these medical interventions.
Bristol-Myers Squibb Children's Hospital
This medical facility provides specialized pediatric care and was involved in the care of these patients.
The details
Patients underwent either bone marrow transplantation or gene therapy to address their sickle cell symptoms. Six-year-old Tiara, one of the patients recognized, successfully received a bone marrow transplant from her brother.
Timeline
September 2026 marked Sickle Cell Awareness Month.
The gathering occurred on Wednesday, September 30, 2026.
The Big Picture
This achievement highlights the clinical success and practical application of research conducted at institutions holding the National Cancer Institute-designated Comprehensive Cancer Center designation. Such outcomes represent a major shift in how hospitals provide definitive cures for formerly chronic genetic disorders.
These successful treatments provide a clear alternative to lifelong symptom management for patients suffering from sickle cell disease. Families dealing with similar conditions may find new hope in these advanced transplantation and gene therapy options.
The takeaway
These successful medical outcomes underscore the importance of early intervention and access to specialized gene therapy and transplant centers. Patients and families are encouraged to consult with specialized hematology teams to discuss the latest curative options for genetic blood disorders.
Further reading
For more information on similar clinical advancements, visit the New Brunswick Stroke section.
More information
For more details on these procedures, read the sickle cell disease information.
